These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3494877)

  • 21. Development of the fetal immune system.
    Siegel I; Gleicher N
    Prog Clin Biol Res; 1981; 70():31-40. PubMed ID: 6458824
    [No Abstract]   [Full Text] [Related]  

  • 22. [Nonspecific immunity factors and elimination of circulating immune complexes in patients with myocardial infarct in the 1st phase of rehabilitation].
    Chan G; Osipov SG; Sipatova MA; Soboleva VA; Nikitin AE
    Kardiologiia; 1985 Aug; 25(8):35-7. PubMed ID: 4068457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distribution of T-lymphocyte subsets in patients with vascular diseases.
    Horváth M; Jovanovich N; Kádár K; Györffy G
    Cor Vasa; 1984; 26(6):429-37. PubMed ID: 6241135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exosomes derived from dendritic cells improve cardiac function via activation of CD4(+) T lymphocytes after myocardial infarction.
    Liu H; Gao W; Yuan J; Wu C; Yao K; Zhang L; Ma L; Zhu J; Zou Y; Ge J
    J Mol Cell Cardiol; 2016 Feb; 91():123-33. PubMed ID: 26746143
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymphotoxin production by subsets of T cells.
    Eardley DD; Shen FW; Gershon RK; Ruddle NH
    J Immunol; 1980 Mar; 124(3):1199-202. PubMed ID: 6153674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro effect of thymosin on T-lymphocyte rosette formation in rheumatic diseases.
    Moutsopoulos H; Fye KH; Sawada S; Becker MJ; Goldstein A; Talal N
    Clin Exp Immunol; 1976 Dec; 26(3):563-73. PubMed ID: 795579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simultaneous production of tumor necrosis factor-alpha and lymphotoxin by normal T cells after induction with IL-2 and anti-T3.
    Steffen M; Ottmann OG; Moore MA
    J Immunol; 1988 Apr; 140(8):2621-4. PubMed ID: 3258616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lymphotoxin production in multiple sclerosis patients.
    Głabiński A; Pokoca L; Tchórzewski H; Selmaj K
    Arch Immunol Ther Exp (Warsz); 1991; 39(3):285-90. PubMed ID: 1810221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Myocardium-sensitized lymphocytes in myocardial infarction].
    Benenson EV; Borisova AM; Mitreĭkin AN
    Ter Arkh; 1981; 53(11):33-5. PubMed ID: 7339901
    [No Abstract]   [Full Text] [Related]  

  • 30. Lymphotoxin and chemotactic factor produced in vitro by human lymphocytes during their proliferative response in the presence of phytohaemagglutinin and Nocardia water-soluble mitogen.
    Prieur AM; Pham Huu T
    Ann Immunol (Paris); 1980; 131D(2):223-32. PubMed ID: 6970542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anticardiolipin antibodies and acute myocardial infarction in non-systemic lupus erythmatosus patients: a controlled prospective study.
    Zuckerman E; Toubi E; Shiran A; Sabo E; Shmuel Z; Golan TD; Abinader E; Yeshurun D
    Am J Med; 1996 Oct; 101(4):381-6. PubMed ID: 8873508
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Two-color flow cytometry analysis of lymphocyte subsets in patients with acute myocardial infarction and post-myocardial infarction syndrome].
    Tsuchihashi M; Sakaguchi Y; Nakamura M; Sutani T; Tsuruta S; Kato S; Uemura S; Nishida Y; Hashimoto T; Kagoshima T
    J Cardiol; 1995 Aug; 26(2):69-79. PubMed ID: 7674146
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytotoxic activity of lymphocytes. VII. cellular origin of alpha-lymphotoxin.
    Yano K; Lucas ZJ
    J Immunol; 1978 Feb; 120(2):385-94. PubMed ID: 146053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Changes in humoral immunity in ischemic cardiomyopathy].
    Muscari A; Bandini A; Fiorentini GP; Mikus PM; Gerratana C; Bozzoli C; Gerardi P; Pecoraro F; Puddu P
    G Ital Cardiol; 1987 Sep; 17(9):731-8. PubMed ID: 3500886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [T- and B-lymphocyte count in myocardial infarct].
    Ananchenko VG; Gulevich NV; Griaznova NA; Rattel'-Tamantsev GI; Strel'tsova TV
    Sov Med; 1981; (1):11-7. PubMed ID: 6972620
    [No Abstract]   [Full Text] [Related]  

  • 36. [Late febrile conditions after acute myocardial infarction with special attention to the post-myocardial-infarction syndrome (PMIS) and the occurrence of myocardioautoantibodies].
    Stahl D; Thyme S; Wanscher B
    Ugeskr Laeger; 1975 Nov; 137(46):2709-14. PubMed ID: 1189085
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effect of infection foci and preexisting pathology on immunological shifts and the course of the disease in myocardial infarct patients].
    Krylov AA; Nesterko AO
    Kardiologiia; 1978 Jul; 18(7):67-70. PubMed ID: 682417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cytotoxic effect of the lymphocytes in ischemic heart disease].
    Kitaev MI; Dvorkin MI; Imanbaev AS; Tiurebaeva BN
    Kardiologiia; 1985 May; 25(5):74-6. PubMed ID: 3874988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T lymphocytes and anticardiac antibodies in patients with ischemic heart diseases.
    Agrawal CG; Gupta SP; Chaturvedi UC; Mitra MK; Gupta NN; Gupta S
    Int Arch Allergy Appl Immunol; 1978; 57(3):246-52. PubMed ID: 306972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Lymphotoxin production by human lymphocytes. III. The action of adenovirus antigen].
    Reĭzenbuk VG; Sarv IR; Tapupere VO; Iyks SR
    Zh Mikrobiol Epidemiol Immunobiol; 1979 Oct; (10):45-9. PubMed ID: 315678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.